在动脉疾病中,Poly ((ADP-ribose) 聚合酶1调节了血管光滑肌肉细胞平衡
Wenjing Xu1,2,3,4, Yichen Wu1,2,3,4, Ruiqi Mao1,2,3,4
1Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Experimental & molecular medicine
|July 31, 2025
概括
聚 ((ADP-ribose) 聚合酶1 (PARP1) 调节血管光滑肌细胞 (VSMC) 的可塑性. 抑制PARP1抑制VSMC切换,为动脉样硬化等血管疾病提供潜在的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 血管光滑肌细胞 (VSMC) 的可塑性对生理过程至关重要,并与血管病理有关.
- 了解VSMC表型切换的调节者对于开发诸如动脉样硬化和静脉复缩等疾病的治疗方法至关重要.
研究的目的:
- 为了研究聚ADP-ribose) 聚合酶1 (PARP1) 作为VSMC可塑性的主调节者的作用.
- 阐明PARP1影响VSMC表型的分子机制.
主要方法:
- 对动物和人类动脉样硬化和狭窄动脉中PARP1激活的分析.
- 在体内和体外的研究涉及VSMC中的PARP1抑制或删除.
- 鉴定PARP1基质和下游信号通路,包括肌肉激素,血清反应因子和c-Jun.
主要成果:
- 在动脉样硬化斑块和狭窄动脉内的VSMC中,PARP1被强烈激活.
- 抑制或删除PARP1抑制了VSMC表型切换.
- 通过PARP1介导的肌肉和血清反应因子的多基化抑制了收缩性蛋白质表达.
- PARP1的激活促进了VSMC的增殖和迁移,通过破坏肌肉和c-Jun.之间的抑制相互作用来促进VSMC的增殖和迁移.
结论:
- PARP1作为VSMC可塑性的关键主调节器,控制了收缩型表型的抑制和合成型表型的促进.
- 准PARP1为由VSMC功能障碍驱动的血管病理提供了潜在的治疗策略.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.4K
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
8.4K
相关概念视频
01:30Atherosclerosis I: Introduction
87
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
87
01:17Autoregulation of Blood Flow
2.8K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.8K
01:16Vascular Spasm
1.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.9K
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
01:30Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33
01:28Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K